CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)—Guidelines of the Infectious Diseases Working Party (AGIHO) of the German S...

por Schmidt-Hieber, M., Silling, G., Schalk, E., Heinz, W., Panse, J., Penack, O., Christopeit, M., Buchheidt, D., Meyding-Lamadé, U., Hähnel, S., Wolf, H. H., Ruhnke, M., Schwartz, S., Maschmeyer, G.
Publicado 2016

VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors

por Röhrig, F, Vorlová, S, Hoffmann, H, Wartenberg, M, Escorcia, F E, Keller, S, Tenspolde, M, Weigand, I, Gätzner, S, Manova, K, Penack, O, Scheinberg, D A, Rosenwald, A, Ergün, S, Granot, Z, Henke, E
Publicado 2017

Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Socie...

por Kochanek, Matthias, Schalk, E., von Bergwelt-Baildon, M., Beutel, G., Buchheidt, D., Hentrich, M., Henze, L., Kiehl, M., Liebregts, T., von Lilienfeld-Toal, M., Classen, A., Mellinghoff, S., Penack, O., Piepel, C., Böll, B.
Publicado 2019

P1448: LONG-TERM SURVIVORS AFTER FAILURE OF CAR-T CELL THERAPY FOR R/R LARGE B-CELL LYMPHOMA (LBCL): A GLA/DRST STUDY

por Derigs, P., Bethge, W., Holtick, U., von Tresckow, B., Ayuk, F., Penack, O., Vucinic, V., von Bonin, M., Baldus, C., Mougiakakos, D., Wulf, G., Schnetzke, U., Stelljes, M., Thomas, S., Schroers, R., Kroeger, N., Dreger, P.
Publicado 2022

P1344: METHODOLOGY OF AN INTERNATIONAL MULTI-CENTER RETROSPECTIVE REVIEW OF TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (TA-TMA) BY THE TA-TMA WORKING GROUP

por Ho, V., Duarte, R. F., Boelens, J.-J., Cairo, M. S., Champlin, R. E., Giralt, S., Hamadani, M., Higham, C. S., Jerkins, J. H., Laurence, J., Mayer, S., Nakamura, R., Penack, O., Perales, M.-A., Rondón, G., Scordo, M., Hingorani, S., Vasu, S.
Publicado 2022

Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society...

por Heinz, W. J., Buchheidt, D., Christopeit, M., von Lilienfeld-Toal, M., Cornely, O. A., Einsele, H., Karthaus, M., Link, H., Mahlberg, R., Neumann, S., Ostermann, H., Penack, O., Ruhnke, M., Sandherr, M., Schiel, X., Vehreschild, J. J., Weissinger, F., Maschmeyer, G.
Publicado 2017

P1458: PATTERNS OF LONG-TERM HEMATOPOIETIC RECOVERY IMPACT SURVIVAL OUTCOMES AFTER CD19-DIRECTED CAR T-CELL THERAPY FOR R/R LBCL

por Rejeski, K., Albanyan, O., Iacoboni, G., Bücklein, V., Blumenberg, V., Penack, O., Bethge, W., Völkl, S., Perez, A., Carpio, C., Schmidt, C., Müller, N., Reid, K., Faramand, R., Davila, M., Bullinger, L., Locke, F., von Bergwelt-Baildon, M., Mackensen, A., Barba, P., Jain, M., Subklewe, M.
Publicado 2022

P1444: IMPACT OF CO-MORBIDITIES ON NON-RELAPSE MORTALITY AND CYTOKINE-RELEASE SYNDROME AFTER CD19 CAR-T CELL THERAPY - A RETROSPECTIVE STUDY FROM THE TCWP OF THE EBMT AND GOCART CO...

por Basak, G., Peczynski, C., Koenecke, C., Terwel, S., Cabrerizo, Y., Penack, O., Moiseev, I., Schoemans, H., Fegueux, N., Potter, V., Zeerleder, S., Yakoub-Agha, I., Collin, M., Schanz, U., Dreger, P., Blaise, D., Besley, C., Glass, B., Mohty, M., Chabannon, C., Kuball, J., Snowden, J., Sureda, A., Kröger, N., Peric, Z.
Publicado 2022

P1447: INFERIOR OUTCOMES OF EU VS. US PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA AFTER CD19 CAR T-CELL THERAPY ARE IMPACTED BY BASELINE RISK FACTORS AND CAR PRODUCT CH...

por Bücklein, V., Perez, A., Iacoboni, G., Rejeski, K., Holtick, U., Penack, O., Kharboutli, S., Blumenberg, V., Ackermann, J., Frölich, L., Johnson, G., Patel, K., Arciola, B., Schmidt, C., Albanyan, O., Gödel, P., Hoster, E., Bullinger, L., Mackensen, A., Locke, F., von Bergwelt, M., Barba, P., Jain, M. D., Subklewe, M.
Publicado 2022